assays:

Viability	20215: Sensitivity measures of MDA-MB-231 and HME-1 cell lines
Viability	20216: Metrics for growth responses of MDA-MB-231 and HME-1 cell lines
Viability	20217: Viability and Apoptosis
RPPA	20218: Phosphorylation State and Protein Levels
Immunofluorescence	20219: Phosphorylation State and Protein Levels
Live-cell imaging	Apoptotic Threshold 1: Live-cell imaging assay
ATAC-Seq	Atac-seq Epigenetic Profiling Assay
Immunofluorescence	BRAF4: Phosphorylation state and levels of signaling
Viability	BRAF5: Viability and apoptosis
Immunofluorescence	BRAF6: Phosphorylation state and levels
Live-cell imaging	Breast Cancer Density: Imaging assay
High content imaging	Breast Cancer HCI1: High content images
High content imaging	Breast Cancer HCI2: High content images
Live-cell imaging	CCCLP1: Phenotypic responses by imaging of CCCLP cell lines
CycIF	CycIF: Highly-multiplexed imaging
Viability	Drug Combination 1: Sensitivity measures of MDA-MB-231 and HME-1 cell lines
L1000	Drug Combination 2: L1000 response of MDA-MB-231 and HME-1 cell lines
Viability	Fluorescence Imaging Cell Viability Assay
Live-cell imaging	FoxO3a Dynamics: Live-cell imaging assay
ATAC-Seq	Global Chromatin Profiling Epigenetic Profiling Assay
L1000	L1000 Gene Expression Profiling Assay
Viability	LJP5&6-growth inhibition/drug combinations
Viability	LJP5&6-growth inhibition/single drugs
MEMA	MEMA Cell Growth Assay
MS Proteomics	MS Protein Quantification Assay
P100	P100 Phosphoprotein Quantification Assay
RNA-Seq	RNA-Seq Gene Expression Profiling Assay
SWATH-MS	Protein Quantification Assay
Secretion	Synovial Fibroblast 1: Secretion response
Secretion	Synovial Fibroblast 2: Secretion response:
Secretion	Synovial Fibroblast 3: Composition of serial dilution
Western Blot	Western Blot / PCR Assay
Western Blot	Western Blot Assay
Proteomics 2: Basal phosphoproteome for 10 ICBP43
KINOMEscan	20227: KINOMEscan
KINOMEscan	20228: KINOMEscan
KINOMEscan	20224: KINOMEscan
KINOMEscan	20221: KINOMEscan
SWATH-MS Protein Quantification Assay
KINOMEscan	20220: KINOMEscan
Proteomics 3: Basal cell surface proteome for the ICBP43
KINOMEscan	20222: KINOMEscan
KINOMEscan	20225: KINOMEscan
Proteomics 1: Basal total proteome for 10 ICBP43
KINOMEscan	20223: KINOMEscan
Synovial Fibroblast 2: Secretion response



cell lines:

184A1-F3aN400
83iSMA-n5
A375
A549
BT20
C32
COLO858
CS00iCTR-n2
CS13iSMA-n1
CS14iCTR-n6
CS25iCTR-18n2
CS28iALS-n2A
CS29iALS-n1N
CS30iALS-n1A
CS32iSMA-n3
CS52iALS-n6A
CS77iSMA-n5
CS83iCTR-33n1
HA1E
HCC1954
HME1
HPAC
HS578T
HT29
HeLa
HeLa+Bcl-2
HeLa+Bcl-XL
HeLa+FLIP-L
HeLa+FLIP-S
synoviocytes	Human fibroblast-like synoviocytes lot #2586
synoviocytes	Human fibroblast-like synoviocytes lot #2645
synoviocytes	Human fibroblast-like synoviocytes lot #2759
synoviocytes	Human fibroblast-like synoviocytes-RA lot #1869
synoviocytes	Human fibroblast-like synoviocytes-RA lot #2159
synoviocytes	Human fibroblast-like synoviocytes-RA lot #2708
synoviocytes	Human fibroblast-like synoviocytes-RA lot 1931
K2
LOXIMVI
MCF10
MCF10A
MCF7
MDAMB231
MMACSF
MZ7MEL
iPSC-derived myocytes	Mount Sinai iPSC-derived myocytes line 1
iPSC-derived myocytes	Mount Sinai iPSC-derived myocytes line 2
iPSC-derived myocytes	Mount Sinai iPSC-derived myocytes line 3
iPSC-derived myocytes	Mount Sinai iPSC-derived myocytes line 4
iPSC-derived myocytes	Myocytes derived from NeuroLINCS iPSCs line 1
iPSC-derived myocytes	Myocytes derived from NeuroLINCS iPSCs line 2
NPC
PC3
Promocell myocytes	Promocell myocytes line 1
Promocell myocytes	Promocell myocytes line 2
Promocell myocytes	Promocell myocytes line 3
Promocell myocytes	Promocell myocytes line 4
RVH421
SKBR3
SKMEL28
WM115
WM1552C
BT549
HCC1806
TBD among cell lines from LJP5&6-growth inhibition/ single drugs
HCC70
~40 cell lines from the ICBP43 panel